Peptide record

TPDB02524

Antibacterial Antifungal Antiviral Toxicity standard
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB02524
Antibacterial Antifungal Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia CAFPdb dbAMP AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 10-aa standard-residue multi-activity (Antibacterial, Antifungal, Antiviral, and other sources) peptide sequence curated from AntiBP3, Peptipedia, CAFPdb, and other sources, with an available 3D structural model.
Sequence
AKVTMTCSAS
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C39H71N11O15S2
RNDEQGHILFPWY
AST
998.18
8.97
1
0
4
+1
0.62
0.530
49.00
Mammalian: 4.4 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
5
Residue Composition
number
2
A
0
R
0
N
0
D
1
C
0
E
0
Q
0
G
0
H
0
I
0
L
1
K
1
M
0
F
0
P
2
S
2
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 1 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 1 M: 1 F: 0 P: 0 S: 2 T: 2 W: 0 Y: 0 V: 1
Chemical Descriptors
10 reviewed residue count
C39H71N11O15S2 sequence-only estimate (linear, free termini)
998.18 sequence-only estimate (linear, free termini)
8.97 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.62 sequence-only estimate (linear, free termini)
0.530 sequence-only estimate (linear, free termini)
Evidence Records 6 records
Evidence 1 Activity

Activity

90% Cytotoxicity
Toxicity
2943 µg/mL
Cytotoxic
90% Cytotoxicity | 2943 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins. | Intervirology | 2018
Evidence 2 Activity

Activity

<2% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
<2% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
In Vitro and In Vivo Anti- Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives. | J Fungi (Basel) | 2021
Evidence 3 Activity

Activity

6.41% Killing
Toxicity
10 µM
Cytotoxic
6.41% Killing | 10 | µM | target cell: Monkey kidney epithelial cells LLC-MK2

Target

Monkey kidney epithelial cells LLC-MK2

Source & Reference

NA
DBAASP
In Vitro and In Vivo Anti- Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives. | J Fungi (Basel) | 2021
Evidence 4 Activity

Activity

11.8% Killing
Toxicity
25 µM
Cytotoxic
11.8% Killing | 25 | µM | target cell: Monkey kidney epithelial cells LLC-MK2

Target

Monkey kidney epithelial cells LLC-MK2

Source & Reference

NA
DBAASP
In Vitro and In Vivo Anti- Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives. | J Fungi (Basel) | 2021
Evidence 5 Activity

Activity

10.29% Killing
Toxicity
50 µM
Cytotoxic
10.29% Killing | 50 | µM | target cell: Monkey kidney epithelial cells LLC-MK2

Target

Monkey kidney epithelial cells LLC-MK2

Source & Reference

NA
DBAASP
In Vitro and In Vivo Anti- Candida Activity and Structural Analysis of Killer Peptide (KP)-Derivatives. | J Fungi (Basel) | 2021
Evidence 6 Activity

Activity

Toxicity
Cytotoxic
Cytotoxicity: [Ref.30654366]<10% cytotoxicity against Vero cells at the concentration of 100µg/ mL.

Source & Reference

NA
DRAMP
Intervirology. 2018 61(4):166-173.